Viscosupplementation, often referred to as rooster-comb injections, in which injections of hyaluronic acid are used to improve knee function, is an alternative to pain medication for treatment of osteoarthritis of the knee. Those with osteoarthritis often have a low level of hyaluronic acid in their joints. Hyaluronic acid, which is a naturally occurring substance found in joint fluid, acts as a lubricant so that bones move smoothly, and as a shock absorber so that joints can bear weight. During viscosupplementation, hyaluronic acid is injected directly into the knee joint; it is typically administered in a series of 1 to 5 injections over several weeks time.

Benefits of viscosupplementation include the following:

It can take several weeks for patients to experience full symptom relief after hyaluronic-acid injections. Side effects associated with viscosupplementation are temporary, and include injection-site pain, swelling, redness and rash; bruising around the joint, or fluid accumulation in the knee. If these reactions occur, they are usually mild and do not last long. Viscosupplementation is most effective for mild-to-moderate cases of osteoarthritis, and may be a good option when osteoarthritis has not responded to anti-inflammatory medication or corticosteroid injections.

AmnioFix modulates inflammation, reduces scar tissue formation, and enhances healing through the use of human amniotic membrane allograft.

Call Today to Schedule Your Appointment

Platelet-rich-plasma (PRP) injections use components of the bodys own blood to stimulate healing. Platelets, which are usually associated with coagulation (clotting), are also, according to recent research, able to assist in mending and strengthening damaged tissue by increasing certain growth factors. During the normal healing process, the body uses platelets to promote new-tissue growth and repair injuries. By supplementing platelet content, the healing process is accelerated.

Platelet-rich-plasma injections can be used to treat a wide range of orthopedic conditions, including the following:

During the PRP-injection procedure, which usually incorporates ultrasound imaging, a small amount of blood is withdrawn from the patient. This blood is processed in a centrifuge to separate its various elements, and concentrate the platelets. The resulting plasma is up to five times more concentrated with platelets than natural blood. Once concentrated, the platelets are loaded, along with some of the patients whole blood, into a sterile syringe, and injected into the patient.

Carticelhttp://www.maci.com/patients/?carticel

Contact Urgent Orthopedic Specialists to learn more about regenerative medicine where we serve the Midland, Odessa, Big Spring, Stanton, Andrews, and every other small town in between!

View post:
Regenerative Medicine Midland Texas | Stem Cell Injections ...

Regenerative medicine (platelet rich plasma, stem cell treatment and tenex) is a non-surgical and natural treatment to stimulate and enhance healing of injuries, such as osteoarthritis, tendinitis, plantar fasciitis, and degenerative musculoskeletal diseases.

Most simply defined, PRP is a platelet count above normal. Platelets are your bodys natural healing particles. When you get an injury, platelets in your blood go to the area of injury. Your platelets release growth factors (programming signals) that tell your brain you have an injury and what type of stem cells to send to the area so you get an appropriate healing response. Once concentrated out of a larger volume of blood, PRP can be injected under ultrasound guidance into the injured area to stimulate and enhance healing. PRP has been shown to be beneficial on conditions such as tendinitis/tendinosis, tendon tears, ligament sprains/tears, muscle tears, and osteoarthritis/ joint pain. PRP can also be used in the spine, where the injections are placed using x-ray guidance after careful confirmation that those structures are indeed the source of pain.

This process involves harvesting your stem cells from your bone marrow in your pelvis and concentrating the stem cells by processing the bone marrow in a specialized centrifuge. After first numbing the area so it isnt painful, a needle is used to withdraw bone marrow from your posterior iliac crest (lower back area). This is the same procedure performed for over 50 years in hematology offices. Special centrifuges are then used to spin the bone marrow and separate out and concentrate the stem cells. The stem cells are then activated with platelet rich plasma (PRP) and injected under ultrasound guidance into damaged tissue or joints. Some of the most common applications of stem cell treatments are for osteoarthritis, avascular necrosis, tendon and ligament sprains/tears, tendinitis/tendinosis labral tears, and muscle tears. Stem cells can also be used in the spine, where the injections are placed using x-ray guidance after careful confirmation that those structures are indeed the source of pain.

Recently, percutaneous ultrasonic tenotomy (UT) has evolved as a potential minimally invasive treatment for tendinopathy. This has been performed at Swedish sports medicine since 2014. It is a novel technique in which phacoemulsification (sound waves) are used to debride (clean up) and aspirate bad tendon tissue through a small incision via a small handpiece. Studies have shown it to be safe and effective at treating tendinopathies in multiple different tendons, including documentation of success in treatment of plantar fasciopathy after previous release. It is most commonly used on Achilles tendinitis, lateral epicondylitis (tennis elbow), medial epicondylitis (golfers elbow), plantar fasciitis/ plantar fascial rupture, patellar tendinitis, quadriceps tendinitis, calcific tendinitis of the shoulder, gluteal tendinitis, and hamstring tendinitis.

Visit link:
Regenerative Medicine | Swedish Medical Center Seattle and ...

Regenerative medicine is an emerging specialty of medicine focused on enhancing the bodys ability to regenerate healthy tissue and overcome disease processes. Regenerative treatments can be used to address symptoms associated with many medical conditions, by unlocking the natural ability of the human body to regenerate healthy tissue, and restore health and function.

In the field of Regenerative Medicine, there are several treatment options commonly offered:

Drawbacks with this option:

-Limited stem cells, if any

-Not very potent

-Foreign cells, therefore risk of rejection

Drawbacks with this option:

-Patient has to undergo an additional procedure in order to harvest tissue.

-The number of stem cells and the potency of the cells decrease as an individual ages.

-Strict regulations in the US limit how this treatment can be performed.

Exosomes are the byproduct of neonatal stem cells , which are most potent.

They are not cells, therefore, they do not carry a risk of rejection.

See original here:
Regenerative Medicine Regenerative Solutions of New Jersey

Genesis Pain and Regenerative Medicine is a leader in the treatment of pain. Dr. Enty is a pain doctor offering in officeand outpatient treatments for neck and back pain, failed back surgery, headaches, arthritis, neuropathy, diseases, joint injuries, soft-tissue injuries and sports related injuries. Genesis pain doctor offers PRP Platelet Rich Plasma and HTA Human Tissue Allograft procedures. Our goal is to maximize patients quality of life and minimize pain associated with specific conditions through non-surgical options.

Persistent pain affects millions of Americans daily and costs individuals and businesses billions of dollars annually from direct medical expenses and lost productivity. Genesis Pain and Regenerative Medicine offer traditional pain management treatments as well as advanced medicine options through regenerative medicine. Our physicians provide a comprehensive approach to the treatment of pain which has proven to achieve the best results. Our approach, which includes working with a team of specialists, takes into consideration not only our patients pain but also any other physical, emotional, psychological or lifestyle difficulties.

See more here:
Don Enty, MD | Genesis Pain and Regenerative Medicine Dr. Don ...

NEW YORK, Feb. 14, 2019 /PRNewswire/ -- This report provides a comprehensive overview of the size of the regenerative medicine market, segmentation of the market (stem cells, tissue engineering and CAR-T therapy), key players and the vast potential of therapies that are in clinical trials. Kelly Scientific analysis indicates that the global regenerative medicine market was worth $28 billion in 2018 and will grow to over $81 billion by 2023, with a CAGR of 23.3% between this time frame. Within this market, the stem cell industry will grow significantly at a CAGR of over x% and reach $x billion by 2023. Tissue engineering is forecast to grow at a CAGR of x% to 2023 and potentially reach $x billion. This report describes the evolution of such a huge market in 15 chapters supported by over 350 tables and figures in 700 pages.

Read the full report: https://www.reportlinker.com/p04876076

An overview of regenerative medicine that includes: stem cells, allogenic and autogenic cells, umbilical cord blood banking, tissue engineering and CAR T therapies. Global regenerative medicine market, global breakdown, application breakdown and leading market players Detailed account of the stem cell industry market by geography, indication and company profiles Profiles, marketed/pipeline products, financial analysis and business strategy of the major companies in this space Focus on current trends, business environment, pipeline products, clinical trials, and future market forecast for regenerative medicine Insight into the challenges faced by stakeholders, particularly about the success vs. failure ratios in developing regenerative medicine drugs and therapies. Insight into the biobanking industry globally and its impact on the overall market Description and data for the prevalence of disease types that are addressed by regenerative medicine, stem cells, tissue engineering and CAR-T therapies Financial market forecast through 2023 with CAGR values of all market segments outlined in the objective SWOT analysis of the global market Geographical analysis and challenges within key topographies including the USA, Japan, South Korea, China and Europe

Key Questions Answered

What is the global market for regenerative medicine from 2017 to 2023? What is the global market for regenerative medicine by geography, through 2023? What is the global market for regenerative medicine by indication, through 2023? What is the global market for the stem cell industry from 2017 to 2023? What is the global market for the stem cell industry by geography, through 2023? What is the global market for the stem cell industry by indication, through 2023? What disruptive technology is advancing the overall regenerative medicine market? What are the major company players in the regenerative medicine, stem cells, tissue engineering and CAR-T industries? What types of clinical trials are currently being performed by stakeholders and major players? What are the strengths, weaknesses, opportunities and threats to the market? Which geographic markets are dominating the space? What are the advantages and disadvantages of the allogenic and autologous stem cell industry? What are the main driving forces of this space? What are the main restraints of the regenerative medicine industry as a whole? What is the current environment of the global cord blood bank industry? What are the global access challenges of the regenerative medicine market? What is the space like in Japan, China, South Korea, USA and Europe? What are the main challenges associated with CAR T therapy? When will the first CAR T therapeutics be approved? What are the current regulations for immunotherapies in USA, Europe & Japan? What are the main manufacturing steps in CAR T therapy? What challenges lie ahead for CAR T production?

Countries Covered Global, USA, Europe, UK, Japan, South Korea, Singapore, Asia/Pacific, ROC

Executive Summary

Regenerative medicine's main objective is to heal and replace organs/cells that have been damaged by age, trauma or disease. Congenital defects can also be addressed with regenerative medicine. Therefore, it's market encompasses dermal wounds, cardiovascular disease, specific cancer types and organ replacement. To that end, regenerative medicine is a broader field and manipulates the body's immune system and regeneration potential to achieve its requirement. Financially speaking, investment into this space is dominated by grants, private investors and publicly traded stocks. Looking forward, the regenerative medicine market is promising for a number of robust reasons including:

Increasing number of potentially successful clinical trials Increasing number of mergers and acquisitions High unmet need in many indications Global penetration, especially in Japan will boost the market

Of course restrictions to this market include strict regulations in certain geographies, and also the level of investment required to support R&D, clinical research, trials and commercialization. Reimbursement strategies are also paramount to success of the overall space.

There are over 700 regenerative medicine companies globally at present, that all together have a $x billion market cap. At present the total regenerative medicine market has more than 500 products commercialized. The regenerative medicine market encompasses a number of key technology submarkets including: Cell therapy including stem cells Tissue Engineering Biomaterials BioBanking

Reconstructive surgeries for bones and joints is the mainstay of the regenerative medicine market. Geographically speaking, due to the dominance of the bone and joint reconstruction market, the US has the biggest space. This is followed by Europe. However, due to recent positive legislation in Japan and Europe, the stem cell arena will grow more substantially in these regions over the next five years. By 2023, it is possible that Europe will surpass the US market with respect to stem cell applications, and this will become more likely if the Trump Administration restricts legislation and funding.

Market Applications & Opportunities for Regenerative TherapiesRegenerative medicine, including cellular and gene therapies will have a significant impact on the expenditure of payers, once reimbursement schemes are optimized. To that end a number of conditions that regenerative medicine tackles is synonymous with an aging population such as Cardiovascular diseases & stroke Diabetes Inflammatory and immune diseases Wound healing and soft tissue regeneration Neurodegenerative diseases e.g., ALS, Alzheimer's and Parkinson's Spinal cord injury Musculoskeletal disorders Ocular disease

Global Financial LandscapeThe last few years have been busy for regeneration medicine, cellular therapeutics and the gene therapy industry, with high investment from pharma giants such as Eli Lilly, BMS, Astra Zeneca and Sanofi. Company partnerships were also in motion that included Kite Pharma and Bluebird/Five Prime, Juno and Fate Therapeutics/ Editas Medicine. One of the highlights was the $x billion, four year deal between CRISPR Technologies and Vertex which indicated that gene editing technologies are cutting edge.

Stem Cell Market Analysis & Forecast to 2023Today the stem cell and regenerative medicine industries are interlinked and over the last number of years have grown substantially. Regenerative medicine replaces or regenerates cells, tissues or organs and in order to achieve this uses produces from the pharmaceutical, biologics, medical device and cell therapy spaces. Therefore, cell therapy, and stem cells come under the umbrella market of regenerative medicine. Cell therapy is a platform by which regenerative medicine can achieve its aim and concentrates on using cells as therapeutics to treat disease. In 2018, the global stem cell market was worth $x billion globally, and this is set to rise to $x billion by 2023 with a CAGR of x%.

Tissue Engineering Market Analysis and Forecast to 2023Tissue engineering was the forerunner of the present regenerative medicine market. The area of biomaterials was developed to use cells and biological material and incorporate them into scaffolds and functional tissues. Some of the main applications of tissue engineered products include artificial skin and cartilage and so this area dominates the dermatology, bone and joint submarket. Wound repair is also a significant area for tissue engineering, with products such as Dermagraft in the market.

The global market for tissue engineering was estimated at $x billion in 2018 by Kelly Scientific analysis. It is forecast to grow at a CAGR of x% to 2023 and potentially reach $x billion. Tissue engineering is being driven by the increase in technology of biomaterials, bioscaffolds and bio 3D printing. The rise in the amount of orthopedic transplantations is demanding the market to produce more innovative solutions such as 3D printed organs. In the long term future, Kelly Scientific forecasts the advance of cutting edge 3D bioprinters in this market place

Biobanking Market AnalysisThe biobanking industry is made up of over 500 public and private blood banks globally. These companies and institutions collect, store and distribute adipose tissue, cord blood and birth tissues, musculoskeletal tissues, pericardium, skin, bone, vascular tissue, autologous and allogeneic cells and other biological samples. They operate by charging a collection fee and then a storage fee, which is usually operational for 20 years. Private banking costs between $1,350 to $2,300 as an initial fee, and then between $100 to $175 per annum for storage. Public banking is free, and a number of hybrid models have been introduced in Europe and Asia to date.

CAR-T IndustryThe CAR-T industry is addressing unmet needs in specific relapsed cancers, however does early clinical trial data support a blockbuster status for this upcoming therapy? Some patients do indeed show long term activity and high remission rates, but there is a large proportion of patients with toxicities such as cytokine release syndrome and neurotoxicity. The main players within the CAR-T market are Juno Therapeutics, Kite Pharma, Novartis and Cellectis. The market is moving ahead, backed by years of R&D, from both academia and industry, investors capitol and small clinical studies. From 2017, Kelly Scientific forecasts that CAR T therapy will become more streamlined, with faster manufacturing times as advances in technologies take hold and clinical trials provide more robust evidence that this immunotherapy is robust. These factors, plus strategies to reduce adverse reactions and toxicities and larger players like Novartis taking stage will push CAR T therapy ahead. However, recent deaths in the Juno ROCKET trial are creating questions amongst investors. How will the CAR T space influence the total immunotherapy industry going forward? This comprehensive report scrutinizes the total market and provides cutting-edge insights and analysis.

Read the full report: https://www.reportlinker.com/p04876076

About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________ Contact Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

Story continues

Excerpt from:
Global Regenerative Medicine Market Analysis & Forecast to ...

Stem cell therapy takes advantage of the special healing quality of stem cells. These cells can help repair damaged tissues in the body. Stem cells are found in your bone marrow. The Sports Medicine physicians at The Orthopaedic Center specialize in both BMAC and PRP treatments.

Bone Marrow Aspirate Concentrate (BMAC) treatment, also known as Bone Marrow Concentrate (BMC) treatment is a non-surgical regenerative treatment for various orthopedic injuries, including moderate to severe osteoarthritis and tendon injures. BMAC is a concentrate of regenerative stem cells obtained from the patients own bone marrow. The physician removes a small amount of the patients bone marrow and uses it to generate a powerful concentrate that is injected into the treatment area.

Unlike other cells of the body, bone marrow cells are undifferentiated, which means they have the ability to transform themselves into a variety of tissue types. When injury occurs, the quantity of regenerative cells needed for tissue regeneration may be inadequate. With BMAC, the injection of regenerative cells provides a more robust healing of damaged tissue and aids in growth and repair by accelerating the bodys natural healing mechanism. While the full benefits of BMAC are still unknown, BMAC has been shown to reduce swelling, relieve pain, and enhance healing of articular cartilage and bone.

Numerous conditions can be considered for treatment with BMAC. Currently, moderate to severe osteoarthritis and severe tendon injuries show promising results.

Knee Osteoarthritis is currently the best indication. Others are listed below.

In general, PRP may be more appropriate for mild to moderate osteoarthritis or tendon injuries. BMAC may be reserved for more challenging cases such as moderate to severe osteoarthritis or when more potent effects are desired.

With the patient sedated, the bone marrow aspiration site is locally numbed so minimal pain is felt. Bone marrow is removed from the back of the pelvis (hip) at the posterior iliac crest. The concentration of bone marrow (stem cells and healing components), also known as the bone marrow aspirate concentrate (BMAC), is injected into the treatment area. Patients go home the same day.

Unlike cortisone/steroid shots which simply mask symptoms (and may damage tissue with repeated injections), BMAC targets the root of the problem and attempts to heal the tissue.

Most patients require only a single BMAC treatment. However, if a patient experiences significant relief that plateaus, they may consider a second BMAC injection months later.

For the first 2-3 days, swelling and discomfort may occur in the injected area. By the end of the first week, these symptoms usually begin to resolve. Physical therapy is started within a few days of the treatment, to optimize BMAC effects and facilitate recovery. Patients respond to BMAC treatment along varying timelines.

Bone marrow derived cancer (such as lymphoma) and active systemic infection are contra-indications. Other types of cancer may be a contra-indication and approval must be obtained from the patients oncologist.

No. While there is evidence showing the positive effects of BMAC treatment on tendon, soft tissue, and cartilage injuries, BMAC is not covered by insurance companies at this time.

Most patients notice some level of improvement by 2-6 weeks following their BMAC treatment. Increases in stability and strength are typically reported, along with the decreases in pain. A second level of benefit may be obtained between 6 weeks and 3 months following BMAC. Patients should remain active with a physical therapy program and strengthen surrounding muscles during this period.

Platelet-Rich Plasma (PRP) is produced from your own blood. Platelets are cells in our body that contain growth factors. These growth factors stimulate the normal wound healing process, such as when your skin heals after a scrape. For PRP treatments, we concentrate your platelets (to over 5x more platelets than your normal blood) and deliver them to the area of interest, to help heal injured tissue. Some PRP treatments are done under ultrasound guidance to confirm placement of the PRP in the correct tissue.

PRP is indicated for injuries that have failed to heal despite traditional treatments. PRP treatments can be performed in any musculoskeletal structure, including muscles, tendons, joints and ligaments. Some examples include: partial tendon tears, muscle strains, ligament sprains/partial tears, articular cartilage injury, and chronic tendon injuries.

To prepare PRP, blood is taken from your arm with a special kit. This is similar to a normal blood draw. The blood is then placed in a centrifuge that separates the platelets from the blood, creating the PRP. The entire PRP treatment process takes about 45 minutes.

Many patients achieve successful outcomes with only one treatment, especially for soft-tissue problems. In some cases, a series of three treatments is required to achieve significant results. This is particularly true for joint treatments. Each treatment is spaced several weeks apart. There is no limit to the number of treatments you can have; however, if youre not seeing significant improvement after three treatments, you should consider other forms of treatment.

Since your own blood is used, there is no risk for transmitted blood-infections. PRP has a strong antibacterial effect so the risk of local infection is minimal. It is possible to have increased soreness or pain for several days after the treatment. You may be prescribed pain medication to help with this.

PRP treatment is a fairly new procedure, and most insurance companies have not incorporated it yet to their list of approved procedures and do not consider it a reimbursable expense. PRP treatment fees include the PRP kit, blood draw, use of centrifugation machine, disposable equipment, ultrasound guidance (if needed), and the actual procedure. A splint for support may be indicated in some cases (additional fee, likely with some insurance coverage).

PRP stimulates healing of the injured tissue by activating your bodys natural healing potential. On average, patients report more than 50% improvement at 6 weeks and up to 100% improvement at 12 weeks after treatment. PRP treatment may eliminate the need for other treatments such as long-term medication or surgery.

Continue reading here:
Regenerative Medicine | Stem Cell Therapy | Huntsville AL